Moderna (MRNA) Change in Acquisitions & Divestments (2018 - 2026)

Moderna (MRNA) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $602.0 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 12.5% year-over-year to $602.0 million in Q1 2026; TTM through Mar 2026 was $5.5 billion, a 77.71% increase from a year earlier, with the FY2025 full-year figure at $5.6 billion, up 40.23% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $602.0 million, down from $929.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for MRNA reached as high as $2.8 billion in Q4 2023 and fell as low as -$526.0 million in Q3 2024.
• Historically, Change in Acquisitions & Divestments has averaged $1.1 billion across 5 years, with a median of $957.0 million in 2024.
• Across the five-year window, Change in Acquisitions & Divestments soared 1368.75% in 2023 and sank 276.51% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $233.0 million in 2022, then jumped by 1123.18% to $2.8 billion in 2023, then slumped by 66.42% to $957.0 million in 2024, then decreased by 2.93% to $929.0 million in 2025, then sank by 35.2% to $602.0 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $602.0 million in Q1 2026, $929.0 million in Q4 2025, and $1.2 billion in Q3 2025.